These findings highlight the importance of considering sex differences in behavioral responses to D1R agonists, but future work is needed to further elucidate the underlying mechanisms of how D1Rs influence anxiety, depression, and locomotion between males and females. This evidence concerns the gene DRD1 and depressive symptom measurement.